复发性局限性膀胱淀粉样变的治疗，甲氨蝶呤有帮助吗？
Management of recurrent localised bladder amyloid, has methotrexate helped?
作者信息
Kelsey E, Holmes A, Tissot S, Campbell P, McLeod K
机构信息
Department of Urology, University Hospital Geelong, Barwon Health, Australia.
Department of Haematology, University Hospital Geelong, Barwon Health, Australia.
出版信息
Urol Case Rep. 2023 Sep 27;51:102577. doi: 10.1016/j.eucr.2023.102577. eCollection 2023 Nov.
BACKGROUND
Amyloidosis of the bladder is a benign condition which can present with a multitude of symptoms including bladder mass, irritative voiding symptoms and haematuria.
CASE PRESENTATION
We report on the investigation and management of a patient with recurrent localised amyloidosis of the bladder, which appears to have been managed fortuitously by concurrent methotrexate prescribed for another indication.
CONCLUSION
We provide further assessment and management with a focus on the possible benefit of methotrexate for management of localised bladder amyloidosis.
背景
膀胱淀粉样变是一种良性疾病，可表现出多种症状，包括膀胱肿块、刺激性排尿症状和血尿。
病例报告
我们报告了一名复发性局限性膀胱淀粉样变患者的检查和治疗情况，该患者似乎因另一种适应症同时开具的甲氨蝶呤而意外得到治疗。
结论
我们提供了进一步的评估和治疗，重点关注甲氨蝶呤对局限性膀胱淀粉样变治疗可能带来的益处。
Zotero 插件